COVID-19 antibodies persist, reduce reinfection risk for up to six months: Study

COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds

Most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months,..